Medicare fee schedule changes little for 2005

Washington, DC-The national deficit and the political implications inherent in causing it to grow even more are two factors that stand in the way of assuring that Medicare has proper funding well into the future.

Related Videos
Related Content

Nanoscope Therapeutics announces positive topline results from Phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa

March 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Retinal scans show eyes as a window to track aging

March 31st 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services

March 30th 2023

Lotilaner ophthalmic solution an effective, safe treatment for Demodex blepharitis

March 30th 2023

Nanoscope Therapeutics announces positive topline results from Phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa

March 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Retinal scans show eyes as a window to track aging

March 31st 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services

March 30th 2023

Lotilaner ophthalmic solution an effective, safe treatment for Demodex blepharitis

March 30th 2023

Nanoscope Therapeutics announces positive topline results from Phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa

March 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Retinal scans show eyes as a window to track aging

March 31st 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services

March 30th 2023

Lotilaner ophthalmic solution an effective, safe treatment for Demodex blepharitis

March 30th 2023
© 2023 MJH Life Sciences

All rights reserved.